Precision Medicine
The legendary singer claims Soon-Shiong and other Altor board members hid the success of a promising cancer and AIDS/HIV drug.
21st Century Cures Act is helping drive expansion in the cellular therapies, with the field valued at $25 billion.
A new website from National Human Genome Research Institute aims to help RNs integrate genomics into their patient care.
Oregon Health & Science University will run analytics against clinical data to deliver decision support to clinicians.
The organizations will build a repository for precision and personalized medicine that they hope new startups will use to innovate.
The startup has the only FDA authorization for direct-to-consumer genetic tests.
The machine learning and data-sharing effort is designed to strengthen, accelerate and potentially expand the delivery of precision medicine in breast cancer care.
Company will continue to push toward digitizing, managing and analyzing genomic big data.
RxMatch, a new service for Intermountain care providers, allows physicians to use patients’ genomics to find the right antidepressant faster than using existing trial-and-error methods.
Macaleer previously co-founded one startup and served as CEO and of another.